Hong Kong Stock Movement | Hengrui Pharmaceuticals (01276.HK) rose nearly 4% in late trading, receiving approval for two clinical trials on the same day, covering psoriasis and stroke prevention.
Zhito Finance APP has learned that Hengrui Pharmaceuticals (01276.HK) rose nearly 4% in late trading. As of press time, it was up 3.88%, at HK$45.5, with a turnover of HK$153 million.
Latest
